This virtually live activity focuses on improving care for patients with urothelial carcinoma with regard to effective risk assessment, individualized treatment selection, and adverse event management. This interactive program integrates didactic presentation with robust case-based discussions between you, your colleagues, and the expert faculty moderator to explore new treatment paradigms and clinical challenges in the treatment of bladder cancer.